Castle Biosciences, Inc. - Common stock — Bilan (NASDAQ:CSTL) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 439.33 M462.57 M447.33 M453.34 M531.24 M578.56 M Total du passif 23.64 M50.83 M48.18 M62.07 M75.4 M107.68 M Total des capitaux propres 415.69 M411.74 M399.15 M391.27 M455.83 M470.87 M Total du passif et des capitaux propres 439.33 M462.57 M447.33 M453.34 M531.24 M578.56 M Dette totale 0———9.74 M10.16 M Dette nette 0———9.74 M-472.64 M

Nouvelles

BTIG abaisse son objectif de cours sur Castle Biosciences en raison de coûts plus élevés

Castle Biosciences T1 2026 : chiffre d’affaires supérieur aux attentes

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know